Background. Insulin resistance increases type 2 diabetes risk in obese adolescents. Thus, quantitative tools measuring insulin sensitivity and secretion are important for risk assessment. Methods. Forty-four obese pubertal adolescents underwent oral glucose tolerance test (OGTT) and frequently sampled intravenous glucose tolerance test (FSIGT). We correlated OGTT-derived whole body sensitivity index (WBISI) with FSIGT-derived insulin sensitivity index (Si). Insulinogenic index (IGI) from OGTT was compared with acute insulin response to glucose (AIRg) from FSIGT. Results. Fasting insulin (r = −.64, P < .0005) and glucose (r = −.39 P ≤ .0005) predicted Si. The OGTT-derived index WBISI correlated with the FSIGT-derived Si (r = .608, P < .0005). IGI correlated with AIRg from FSIGT (r = .704, P < .0005). Conclusions. OGTT-based measures correlated with FSIGT-derived measures of insulin sensitivity and secretion. In particular, we demonstrated that WBISI can be a reliable alternative to FSIGT-derived Si in clinical settings where OGTT is a more feasible option.
FlegalKMCarrollMDOgdenCLCurtinLR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235-241.
2.
DavidsonMB. Clinical implications of insulin resistance syndromes. Am J Med. 1995;99:420-426.
3.
BachaFLeeSGungorNArslanianS. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care. 2010;33:2225-2231.
4.
GungorNSaadRJanoskyJArslanianS. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr. 2004;144:47-55.
5.
DeFronzoRATobinJDAndresR. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
6.
GungorNArslanianS. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr. 2004;144:656-659.
7.
BergmanRNPhillipsLSCobelliC. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981;68:1456-1467.
8.
BergmanRNPragerRVolundAOlefskyJM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987;79:790-800.
9.
MoranAJacobsDRSteinbergerJ. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039-2044.
10.
CutfieldWSBergmanRNMenonRKSperlingMA. The modified minimal model: application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab. 1990;70:1644-1650.
11.
ConwellLTrostSBrownWBatchJ. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care. 2004;27:314-319.
12.
GeorgeLBachaFLeeSTfayliHAndreattaEArslanianS. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab. 2011;96:2136-2145.
13.
WeyerCBogardusCMottDMPratleyRE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999;104:787-794.
14.
MatsudaMDeFronzoRA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-1470.
15.
YeckelCWeissRDziuraJ. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab. 2004;89:1096-1101.
16.
MarshallWATannerJM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.
17.
MarshallWATannerJ. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-23.
18.
OgdenCLKuczmarskiRJFlegalKM. Centers for Disease Control and Prevention 2000 Growth Charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2000;109:45-60.
19.
RickelsMRNajiATeffKL. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. J Clin Endocrinol Metab. 2006;91:2138-2144.
20.
BostonRCStefanovskiDMoatePJSumnerAEWatanabeRMBergmanRN. MINMOD millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. 2003;5:1003-1005.
21.
MatthewsDRHoskerJPRudenskiASNaylorBATreacherDFTurnerRC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
22.
HaffnerSMKennedyEGonzalezCSternMPMiettinenH. A prospective analysis of the HOMA model: the Mexico City diabetes study. Diabetes Care. 1996;19:1138-1141.
23.
AndersonRLHammanRFSavagePJ. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests: the Insulin Resistance Atherosclerosis Study. Am J Epidemiol. 1995;142:724-732.
24.
HaffnerSMHowardGMayerE. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic Whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes. 1997;46:63-69.
25.
BuntJCKrakoffJOrtegaEKnowlerWCBogardusC. Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations. Diabetes Metab Res Rev. 2007;23:304-310.
26.
SinhaRFischGTeagueB. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802-810.
27.
GodslandIFJeffsJAJohnstonDG. Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia. 2004;47:1157-1166.
28.
UtzschneiderKPrigeonRFaulenbachM. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care. 2009;32:335-341.
29.
RetnakaranRQiYGoranMIHamiltonJK. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabetic Med. 2009;26:1198-1203.
30.
HendersonMRabasa-LhoretRBastardJP. Measuring insulin sensitivity in youth: how do the different indices compare with the gold-standard method?Diabetes Metab. 2011;37:72-78.
31.
ShaibiGQDavisJNWeigensbergMJGoranMI. Improving insulin resistance in obese youth: choose your measures wisely. Int J Pediatr Obes. 2011;6:e290-e296.
32.
YeckelCTaksaliSDziuraJ. The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance. J Clin Endocrinol Metab. 2005;90: 747-754.
33.
HendersonMBaillargeonJPRabasa-LhoretRChiassonJLHanleyJLambertM. Estimating insulin secretion in youth using simple indices derived from the oral glucose tolerance test. Diabetes Metab. 2012;38:309-315.
34.
TfayliHLeeSArslanianS. Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in children. Diabetes Care. 2010;33:2024-2030.
35.
SjaardaLGBachaFLeeSTfayliHAndreattaEArslanianS. Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index. J Pediatr. 2012;161:51-57.
36.
RetnakaranRShenSHanleyAVuksanVHamiltonJZinmanB. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity. 2008;16:1901-1907.
